KORU Medical Systems, Inc. (KRMD) Stock Score, Valuation & Financial Research
KORU Medical Systems, Inc. is in the Healthcare sector and Medical - Instruments & Supplies industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 28/100.
Quick answer for KRMD
KORU Medical Systems, Inc. currently has a Wall Street Score of 28/100. The stored market price is $3.16. Its financial score is 25/100. Its valuation score is 0/100. These figures are a research snapshot, not a buy or sell recommendation.
What KORU Medical Systems, Inc. does
KORU Medical Systems, Inc. is dedicated to the development, manufacturing, and commercialization of mobile medical devices, primarily serving the ambulatory infusion market across both the United States and international territories. The company's primary offerings revolve around mechanical infusion solutions, notably their FREEDOM infusion systems. These comprehensive systems encompass components such as the FREEDOM60 and FreedomEdge syringe drivers, alongside specialized HIgH-Flo subcutaneous safety needle sets and precision flow rate tubing. Beyond their product range, KORU Medical also supplies educational content and training materials to healthcare professionals, patients, and patient advocates. The distribution of their products is managed through a combination of direct sales efforts, partnerships with medical device distributors, and online channels. Established in 1980, the fir
KRMD financial snapshot
- Wall Street Score:
- 28/100
- Current price:
- $3.16
- Market capitalization:
- $145.1M
- Revenue:
- $43.3M
- Net income:
- $-2.3M
- Free cash flow:
- $-470K
- Cash:
- $8.8M
- Total debt:
- $3.4M
- EPS:
- -0.06
- Financial score:
- 25/100
- Valuation score:
- 0/100
- Revenue score:
- 24/100
What stands out
- Reported year-over-year revenue growth is +0.1%.
- Free cash flow is $-470K, showing cash burn in the current stored period.
- The balance sheet shows $8.8M of cash versus $3.4M of total debt, leaving more cash than debt.
What the numbers mean
Its current valuation score is 0/100, which Wall Street Score classifies as weak within the model's valuation framework.
The financial score is 25/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-07-24.
How to research KRMD
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.